Literature DB >> 17690017

A randomized clinical trial of targeted cognitive behavioral treatment to reduce catastrophizing in chronic headache sufferers.

Beverly E Thorn1, Laura B Pence, L Charles Ward, Gary Kilgo, Kristi L Clements, Tony H Cross, Amber M Davis, Patricia W Tsui.   

Abstract

UNLABELLED: This randomized clinical trial (RCT) examined the efficacy of a cognitive-behavioral treatment (CBT) specifically targeted toward reducing pain catastrophizing for persons with chronic headache. Immediate treatment groups were compared with wait-list control groups. Differential treatment gains based on the order of presentation of 2 components of CBT (cognitive restructuring and cognitive/behavioral coping) and the role of catastrophizing in treatment outcome were examined. Thirty-four participants enrolled in a 10-week group treatment and 11 completed a wait-list self-monitoring period. Participants reported significant reductions in catastrophizing and anxiety and increased self-efficacy compared with wait-list control subjects, and these were maintained at follow-up. Although we did not find overall differences in the reduction of headache frequency or intensity compared with wait-list control subjects, calculation of clinical significance on headache indicators suggest that approximately 50% of treated participants showed meaningful changes in headache indices as well. Order of treatment modules was not related to gains during treatment or at follow-up; however, almost all changes occurred during the second half of treatment, suggesting that duration of treatment participation is important. PERSPECTIVE: Cognitive-behavioral treatment targeting reduction of catastrophizing for chronic headache pain reduced negative cognitive and affective variables associated with recurrent headache, increased headache management self-efficacy, and in half of the participants, produced clinically meaningful reductions in headache indicators. Length of treatment is an important factor to consider when providing CBT for chronic pain.

Entities:  

Mesh:

Year:  2007        PMID: 17690017     DOI: 10.1016/j.jpain.2007.06.010

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  51 in total

1.  A qualitative analysis of a randomized controlled trial comparing a cognitive-behavioral treatment with education.

Authors:  Melissa A Day; Beverly E Thorn; Shweta Kapoor
Journal:  J Pain       Date:  2011-08-11       Impact factor: 5.820

2.  Cognitive processes in comorbid poor sleep and chronic pain.

Authors:  Haley D Byers; Kenneth L Lichstein; Beverly E Thorn
Journal:  J Behav Med       Date:  2015-10-12

3.  Utility of the NEO-FFI in multi-dimensional assessment of orofacial pain conditions.

Authors:  John E Schmidt; W Michael Hooten; Charles R Carlson
Journal:  J Behav Med       Date:  2010-10-02

4.  Catastrophizing, pain, and pain interference in individuals with disabilities.

Authors:  Adam T Hirsh; Tamara B Bockow; Mark P Jensen
Journal:  Am J Phys Med Rehabil       Date:  2011-09       Impact factor: 2.159

5.  Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial.

Authors:  Steven Z George; Roland Staud; Paul A Borsa; Samuel S Wu; Margaret R Wallace; Warren H Greenfield; Lauren N Mackie; Roger B Fillingim
Journal:  Contemp Clin Trials       Date:  2017-03-14       Impact factor: 2.226

Review 6.  [Psychological therapy of migraine: systematic review].

Authors:  G Fritsche; B Kröner-Herwig; P Kropp; U Niederberger; G Haag
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

7.  Determinants of pain treatment response and nonresponse: identification of TMD patient subgroups.

Authors:  Mark D Litt; Felipe B Porto
Journal:  J Pain       Date:  2013-10-02       Impact factor: 5.820

8.  Pain catastrophizing in borderline morbidly obese and morbidly obese individuals with osteoarthritic knee pain.

Authors:  T J Somers; F J Keefe; J W Carson; J J Pells; L Lacaille
Journal:  Pain Res Manag       Date:  2008 Sep-Oct       Impact factor: 3.037

Review 9.  Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.

Authors:  Beth D Darnall; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

10.  Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disability.

Authors:  Tamara J Somers; Francis J Keefe; Jennifer J Pells; Kim E Dixon; Sandra J Waters; Paul A Riordan; James A Blumenthal; Daphne C McKee; Lara LaCaille; Jessica M Tucker; Daniel Schmitt; David S Caldwell; Virginia B Kraus; Ershela L Sims; Rebecca A Shelby; John R Rice
Journal:  J Pain Symptom Manage       Date:  2008-11-28       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.